Erector Spinae Versus Intercostal Nerve Blocks With Liposomal Bupivacaine for Analgesia in Thoracic Surgery

NCT06810375 · George Washington University

Recruiting

In plain English

Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.

About this study

This clinical trial compares efficacy in postoperative pain management in thoracic surgery between erector spinae block versus liposomal bupivacaine injections.

Eligibility criteria

Inclusion Criteria: * Video assisted pulmonary resection, pleurodesis or decortication Exclusion Criteria: * Allergy to local anesthetics * Patient undergoing bilateral surgery * Surgery is emergent as deemed by the principal investigator

Study design

Enrollment target: 120 participants

Allocation: randomized

Masking: none

Age groups: adult, older_adult

Timeline

Starts: 2025-03-01

Estimated completion: 2029-02-28

Last updated: 2026-04-09

Interventions

Drug: Erector Spinae (ESP) Block with Bupivacaine (Marcaine®)Drug: Intercostal nerve block

Primary outcomes

• Postoperative pain control assessment (Up to 48 hours postoperatively)
• Morphine equivalent assessment (Up to 72 hours postoperatively)

Sponsor

George Washington University · other

Contacts & investigators

ContactEduard Shaykhinurov, MS · contact · eshaykhinurov@mfa.gwu.edu · 2022038960

All locations (1)

The George Washington University HospitalRecruiting

Washington D.C., District of Columbia, United States

View on ClinicalTrials.gov ↗Find similar trials